_ W } F-u X i s * . -_ _. . . .: s n x ; i i _ , * z' . '', ? , 0 & § l1 1 1._ , i>g l g b iZ 2 j^1 111 | _ -Z s -;X.z.0z'.^>X..C<.0 S | _ y g x x z -. r z w . . a E G l _ _ _ _ _ _ _ _ , F 3 ; . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . : ; _ A . . . . . . . . . . . . . . . . : 8 ; § . , Y N * ' _ . * 9 e s s . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . o , > . : _ : _ _ : e . i . . . . . . . . . . . . . . . . . . . . . -e z 4 e : -. . . . . . . . . , . : . z > S 9 = ? = _ = | ? w : s : c . * : 7 : t 4 . 4 2 " a i : : . : ' . z ! . 6 s 1 i . 1 1 1 | | _ a a i ; 9 _ . M f f l -_ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . : S -_ : : , i . , ; y s R § . . . . . . . . . . . . . . . . . . . . . . . . . . / g : . Y . . . --| l * | .:.. _,... Wco>Z 10 I _ : : , 3 . _ : : X < _ g s s -z g e i p : f f i i g z z A g > . ' 3 § E f z e 4 . ; . : * _ j F > . . ; ; . . There are four points for comment. (1) Both Case 1 and Case 2 had hair which showed increased fragility, a feature probably responsible for the localized areas of short hair. (2) Mrs W S (111.3) was only mildly affected, illustrating variability of expression of the gene commonly seen in conditions inherited as an autosomal dominant trait. (3) Case 1 had folliculitis and blepharitis. A folliculitis of the scalp has been reported before (Peachey & Wells 1971) , and the blepharitis may be related. (4) The scalloped appearance of the hair seen in cross-section under the microscope is characteristic of this disorder, but is not pathognomic. Dr Ian Martin-Scott: This case reminds me of an Italian family shown to this Section (Martin-Scott I, 1947, Proceedings of the Royal Society of Medicine 40, 701) with similar hair changes. The mother had sparse twisted hair and her two sons who were bald at birth were seen in early adolescence. They had coarse twisted scalp hair, few eyebrows and lashes but were otherwise physically and mentally normal. affected subjects is likely to be permanent. In our cases scalp biopsies from 4 affected individuals all showed a reduction in pilosebaceous follicles with evidence of perifollicular scarring. Two of the biopsies showed foreign body reactions arsund follicular remnants.
Pigmentary Changes Following Chloroquine
Philip Marriott MRcP and P F Bornie FRcP (St Bartholomew's Hospital, London ECIA 7BE) D D, white woman aged 62 History: Presented in May 1973 with a one-year history of red scaling patches on the face, scalp and neck. A clinical diagnosis of discoid lupus erythematosus was made and, following failure of topical steroids, she was started on chloroquine 200 mg twice daily in June 1973. There was rapid resolution of the lupus lesions. By December 1973 chloroquine had been reduced to 100 mg daily.
Ophthalmological examination every three months showed normal maculhe and full visual acuity. Chloroquine was stopped at the end of May 1974. The patient first noticed her hair lightening one month after the withdrawal of the drug. On examination: Depigmentation of hair exposed to the light (Fig IA) . Hair unexposed to the light 536 Proc. roy. Soc. Med. Volume 68 August 1975 26 A~~~~~~~~~~~~B~~~~~~~~~~F ig 1IA, hair bleaching andskin pigmentationfollowing chloroquine. B, original black hair showed its original black pigment ( Fig I1B) . Generalized increase in pigmentation but, in particular, slate grey pigmentation over the shoulders, around the eyes and neck. Active discoid lupus erythematosus on left temple.
Comment
Blue-black pigmentation is the more common change complicating chloroquine therapy. Its nature is uncertain although pigment scattered throughout the dermis takes stains for heamosiderin, and Mallory's and silver stains. Hair bleaching is also well recognized, documented cases occurring in fair or red-headed patients. The pigment in the patients with fair and red hair is said to be phecomelanin formed from tyrosine via dopa and dihydroxyindole. Tuffanelli (Abraham et al. 1963) reported that 4 out of 5 patients with retinal damage also had skin pigmentation. This patient is unusual being the first presented to the Society with both skin pigmentation and hair depigmentation following chloroquine -therapy. Dr Anne Maguire: Some years ago when I was involved in work on chronic discoid lupus erythematosus, I discovered from various research papers published at the time that the excretion period of chloroquine after the last dose administered is in the neighbourhood of five years; that is to say, five years must elapse before the body is free of the drug.
If pigmentation due to antimalarial administration appears either on the skin, hard palate or nail beds, the patient is at risk for the development of visual difficulties. Corneal opacities occur quite regularly. It is not perhaps so well recognized that whilst there is visible pigmentation, there is a distinct possibility of the occurrence of sudden blindness due to deposition of pigment in the retine.
Dr N R Roweli: I have seen several patients with pigmentary disturbances from chloroquine. Pigmentation occurs particularly on the shins, distal part of the nails and on the palate. Loss of hair pigment may involve the scalp, eyebrows, and moustache in males, and can occur in dark-haired patients. One man's dark hair, eyebrows and moustache did not go white provided chloroquine was administered for two weeks only in every four.
The following cases were also presented: 
